This week there are potentially four names up to list for the first time. Unfortunately for three of them the world will be focused all on one name and that name is Lyft (LYFT  ). If, for some reason you are not interested in what happens with Lyft you still have two biotech's and a blank check company to choose from.

First up, and the largest of the week is Lyft. After a highly publicized prep the company is expected to hit the market this week. The popular ridesharing app will beat rival Uber to the public markets. Reports show that the IPO is currently oversubscribed so many believe it will price higher than their initial range of $62 - $68. Lyft is looking to raise $2 billion and will offer 30.7 million non-voting class shares.

There are two biotech names up for grabs this week. The first, and the largest offering in the group is Genfit (GNFT  ). Based out of France this is a late stage offering which is focused on medications for NASH and will be offering 5 million shares. At a price of $26.33 they are looking to raise about $132 million.

The other biotech is based here in the states (North Carolina) and is a cancer focused medical therapy company. Precision BioSciences (DTIL  ) is an early stage offering which will be offering 7.9 million shares at a range of $15 - $17 in hopes of raising $126 million.

The last offering of the week is 8i Enterprises Acquisitions (JFKKU  ) which is a blank check company looking to acquire businesses in Asia. They are focused on fast growth, younger companies and will look for $50 million by offering 10 million shares at $10.